Neuroinflammation and amyloid-beta 40 are associated with reduced serotonin transporter (SERT) activity in a transgenic model of familial Alzheimer’s disease

Neuroinflammation and amyloid-beta 40 are associated with reduced serotonin transporter (SERT) activity in a transgenic model of familial Alzheimer’s disease

Abstract Background Discrepant and often contradictory results have accumulated regarding the antidepressant and pro-cognitive effects of serotonin transporter (SERT) antagonists in Alzheimer’s disease. Methods To address the discrepancy, we measured the activity and density of SERT in the neocortex...

Full description

Bibliographic Details
Main Authors: Athanasios Metaxas, Marco Anzalone, Ramanan Vaitheeswaran, Sussanne Petersen, Anne M. Landau, Bente Finsen
Format: Article
Language:English
Published: BMC 2019-05-01
Series:Alzheimer’s Research & Therapy
Subjects:
Alzheimer’s disease
APP swe /PS1 dE9
Amyloid-beta
SSRIs
Serotonin transporter
DASB
Online Access:http://link.springer.com/article/10.1186/s13195-019-0491-2

Internet

http://link.springer.com/article/10.1186/s13195-019-0491-2

Similar Items